Company intelligence / Profile preview
Regrow Biosciences
Mumbai (Andheri Kurla Road HQ), Maharashtra, Indiaregrow.in ↗
- Ownership
- Private
- Employees
- ~115
- Development stage
- Commercial
01
Overview
Regrow Biosciences has developed and commercialized patient-specific regenerative therapies, including bone cell therapy for AVN. The company claims successful clinical trials with over 1500 patients treated and regulatory recognition from the US FDA and EMA for its Ossgrow® product.
- Therapeutic areas
- RheumatologyMen's Health
- Modalities
- Cell therapyStem cell therapy
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
340 doctor-partner network across 46 Indian cities [1]. No major pharma partnerships listed.
Beyond the preview
Go deeper on Regrow Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Regrow Biosciences.